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Abstract
Background: The aim of the study was to describe school attendance and participation in physical education in
school among children with juvenile idiopathic arthritis (JIA).
Methods: Consecutive cases of JIA from defined geographical areas of Finland, Sweden and Norway with disease
onset in 1997 to 2000 were followed for 8 years in a multi-center cohort study, aimed to be as close to population-
based as possible. Clinical characteristics and information on school attendance and participation in physical
education (PE) were registered.
Results: Participation in school and in PE was lowest initially and increased during the disease course. Eight years
after disease onset 228/274 (83.2%) of the children reported no school absence due to JIA, while 16.8% reported
absence during the last 2 months due to JIA. Full participation in PE was reported by 194/242 (80.2%), partly by
16.9%, and none by 2.9%. Lowest participation in PE was found among children with ERA and the undifferentiated
categories. Absence in school and PE was associated with higher disease activity measures at the 8-year visit.
School absence > 1 day at baseline predicted use of disease-modifying anti-rheumatic drugs, including biologics
(DMARDs) (OR 1.2 (1.1–1.5)), and non-remission off medication (OR 1.4 (1.1–1.7) 8 years after disease onset.
Conclusion: School absence at baseline predicted adverse long-term outcome. In children and adolescents with
JIA participation in school activities is mostly high after 8 years of disease. For the minority with low participation,
special attention is warranted to promote their full potential of social interaction and improve long-term outcome.
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Background
Juvenile idiopathic arthritis (JIA) is an umbrella term
for chronic childhood arthritis and a significant con-
tributor to chronic disease in children and adolescents.
Even in the era of modern treatment with improved
outcome on biologic therapies, many children with JIA
still experience flares and difficulties to attend daily life
activities [1–3].
Children’s right to education is a fundamental human
right according to the United Nations [4]. In addition to
education, school provides a basic arena for developing a
broad range of cognitive and social skills. An increased
school absence rate is in general associated with anxiety
disorders, increased social isolation, school dropout and
lower educational level [5]. Participation is a key issue in
the International Classification of Functioning, Disability
and Health (ICF), endorsed by the World Health
Organization (WHO) [6]. One of the main factors influ-
encing participation is a child’s health condition in
addition to personal and environmental determinants,
according to the ICF [6]. Physical education in school
aims not only to provide physical activity, but also to
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teach the young person an active life style and increase
lifelong physical fitness [7]. All forms of physical activity
are now generally recommended and encouraged for
children with JIA, replacing the previous traditions of
giving advice to avoid certain activities [8]. Limited
reports exist on participation in school and in physical
education in JIA, and most reports are convenience-
sampled, recruited from hospital cohorts, cross-sectional
or with short follow-up time, and the studies are often
small [3, 9–11].
We have previously performed a longitudinal cohort
study of JIA in a population-based setting in the Nordic
countries [12]. The data of the Nordic JIA cohort on par-
ticipation in school and physical education was analyzed
in the present study. The main objective was to describe
school attendance and participation in physical education
during the study period 8 years after disease onset in a
population-based setting, and to assess the association
with baseline and long-term disease characteristics.
Methods
Patients and study design
Children with a follow-up visit 8 years after onset of
arthritis were selected to our study on participation in the
prospective multicenter Nordic JIA cohort [12, 13]. The
original multicenter cohort consisted of children with newly
diagnosed JIA according to the International League of
Associations for Rheumatism (ILAR) classification criteria,
with disease onset in 1997–2000. Pediatric rheumatologists
at 12 different centers sent during the period repeated
letters to other rheumatologists, orthopedic or pediatric
specialists, and the primary health care in their areas,
informing about the study and asking for referral of all
eligible children. These measures were taken to include all
consecutive children diagnosed with JIA from defined geo-
graphical area covering large parts of Denmark, Finland,
Norway and Sweden, aiming for the cohort to be as close
as possible to population-based [12, 13]. Information on
school issues were missing for the majority of the Danish
participants, and the Finnish patients did not fill in such in-
formation until the eight-year visit. Danish participants
were therefore excluded from the present study, and
Finnish patients were excluded from analyses of the base-
line, the one-year and the three-year visits, in order to keep
the population-based approach of including all eligible chil-
dren in the defined geographical areas. Only children in
school age in the Nordic countries, defined as 6 years or
more of age, with information on school absence and/or
physical education were included in analyses at the specific
time-points.
Data acquisition
Clinical information including family history, assessment
of disease activity, and self-reported questionnaires were
registered per protocol at baseline, at one-year and then
at 1–3-year interval and at a pediatric rheumatology
study visit collecting more extensive data on remission
and damage, approximately 8 years after disease onset
[12]. The parent, or parent together with the child if
aged ≥9 years, filled in self-reported information on
participation in school and physical education. The
number of days of school absence due to JIA during the
last 2 months before the study visit was reported, includ-
ing hospital visits and other treatment-related absence.
Since the information was collected on a day of a hos-
pital visit, we chose to report the number of children
with JIA-related absence of more than 1 day. In the
same way we collected self-reported information on full,
partly or no participation in physical education class in
school. In Scandinavia physical education is an obliga-
tory part of school, usually 1–4 sessions per week, and
children with JIA and other chronic diseases may have a
“doctor’s excuse” and/or a formally modified alternative
physical education program for partial or no participa-
tion. The cohort was recently re-examined 18 years after
disease onset, but the majority had then finished compul-
sory school, and at baseline many children were under
school-age. The eight-year visit taking place in 2005–2007
was therefore most informative regarding participation in
school and PE for the main analyses of this study. We re-
port data at baseline, one-year, three-year and eight-year
visits, but because some children had not started school at
baseline and some had graduated at the 8-year visit, predic-
tion analyses of baseline school absence on adverse long-
term outcome was performed only for the individuals with
information available at both time points. The Child Health
Assessment Questionnaire (CHAQ) is a validated disease-
specific tool to assess functional ability (range 0–3, higher
score indicating increasing functional impairment) and was
filled in by children aged ≥9 years, otherwise by their par-
ents [14, 15]. The Child Health Questionnaire Parent Form
(CHQ-PF50) is a generic tool consisting of 50 items
assessing health-related quality of life, yielding a physical
summary score (PhS), as well as a psychological summary
score (PsS) (range 0–100, lower score indicating impaired
functional ability, US healthy reference children have a
mean score of 50) [14, 16]. Disease activity was assessed
using the Juvenile Arthritis Disease Activity Score (JADAS)
[17]. Joint damage was reported using the Juvenile Arthritis
Damage Index of articular damage (JADI-A) ranging from
0 to maximum of 72 [18]. Remission was defined according
to the preliminary Wallace criteria [19]. Detailed descrip-
tion of the methods of patient accrual and data collection
has been previously published [20].
Statistical analyses
Statistical analyses were performed using the STATA
version 15 software (STATA Corp., College Station, TX,
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USA). Descriptive statistics were used to summarize clin-
ical characteristics of the population and disease activity
measures. The chi-square and Fischer’s exact tests were
used as appropriate for comparison of dichotomous vari-
ables, and the Mann-Whitney U-test for comparison of
medians for skewed data. The Student’s t-test was used to
compare means in continuous outcomes between groups.
Univariate logistic regression was performed to assess
variables cross-sectionally associated with the outcomes;
school absence > 1 day and not participating fully in PE at
baseline and at the eight-year visit. Univariate logistic re-
gression was performed to assess school absence > 1 day
at baseline as a predictor of adverse outcome in terms of
using systemic medication during the disease course, not
being in remission and school absence at the eight-year
visit only for children that had relevant information
available at both timepoints. For variables with p < 0.05 in
the univariate logistic regression analyses, a multivariable
logistic regression was performed adjusting for gender, age
and other relevant variables. A p value < 0.05 was consid-
ered significant.
Results
Altogether 347 Norwegian, Swedish and Finnish children
participated in the Nordic cohort with a long-term
follow-up. Among these, 99 Swedish and Norwegian
children aged 6 years or more with information on par-
ticipation in school and/or PE were included in analyses
at the baseline visit median 6 (IQR 6–8) months after
disease onset, since the Finnish children (n = 138) lacked
information on participation in the first years of the
study, and the Danish children (n = 93) lacked all infor-
mation on participation. The corresponding number of
children were 98 at the one-year visit median 13 (IQR
12–15) months, and 125 at the three-year visit median
37 (IQR 36–45) months after disease onset. Among the
347 children with eight-year follow-up, information on
participation in school and/or PE was available in 285
(82.1%) children, including Finnish participants at the
eight-year visit. Demographic and clinical characteristics
of the children with and without information on partici-
pation is shown in Table 1. Among the 285 children,
66.0% were female and 50.9% had oligoarticular JIA. The
median age was 5.3 (IQR 2.3–9.4) years at onset of
disease, and 13.6 (IQR 10.6–17.6) years at the eight-year
study visit.
School attendance
Mean school absence during the last 2months because of
JIA was 2.7 days at baseline, 1.7 days at the one-year visit,
and 1.5 days at the three-year visit. At baseline 56/95
(58.9%) children reported no school absence because of
JIA within the last 2 months before the study visit, 39
(41.1%) reported more than 1 day, 24 (25.3%) reported
more than 3 days, and 13 (13.7%) reported more than 5
days, as shown in Fig. 1. No school absence because of JIA
was reported by 60 (61.9%) children at the one-year visit,
and by 90 (73.8%) at the three-year visit (Fig. 1). Eight
years after disease onset, 228/274 (83.2%) reported no
school absence because of JIA, while 46 (16.8%) reported
more than 1 day of absence, 18 (6.9%) reported more than
3 days and 12 (4.4%) reported more than 5 days (Fig. 1).
School absence because of JIA within the last 2 months
before the eight-year study visit was mean 1.1 days. In
Table 2 the characteristics of the cohort are shown ac-
cording to school absence 8 years after disease onset.
There was no impact of gender, age at visit, nor BMI on
school attendance. There were no significant differences
in school attendance between JIA categories (p = 0.078,
Fischer’s exact test, results not shown). Children with
more than 1 day absence had significantly lower CHQ
physical summary score (41.8 (IQR 32.1–50.4)) than chil-
dren with full school attendance (53.4 (IQR 47.9–57.3)),
while there were no differences in CHQ psychosocial
summary score (Table 2).
Participation in physical education in school
At baseline 6 months after disease onset 44/89 (49.4%)
reported full participation in PE, partly participation was
reported by 33 (37.1%), and 12 (13.5%) did not partici-
pate, as shown in Fig. 2. Full participation increased over
time to 52.4% of the children at the one-year visit and
63.7% at the three-year visit. Eight years after disease on-
set full participation in PE was reported by 194/242
(80.2%), partly participation by 41 (16.9%), and 7 (2.9%)
reported no participation (Fig. 2). Table 3 shows the
characteristics of PE participation at the eight-year visit.
Significantly fewer girls than boys participated fully in PE
(p = 0.01). Higher BMI (p = 0.01) were associated with less
participation in PE. Children that did not participate fully
in physical education had significantly lower CHQ phys-
ical and also psychosocial summary scores, as shown in
Table 3. Fewer children participated fully in PE in the
enthesitis-related arthritis (ERA) (65.0%) and the undiffer-
entiated (61.8%) categories, while participation was high-
est in the oligoarticular persistent category (93.6%)
(Table 4). Among the 46 children with school absence
more than 1 day at the eight-year visit, 22/41 (53.7%) did
not participate or participated only partly in physical
education. Information on participation in PE was missing
in five of these children.
Associations between participation and disease
characteristics
In univariate analyses, lower school attendance at the
eight-year visit was significantly associated with higher
number of active and cumulative joints, higher level of
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pain and global disease impact on overall well-being
assessed by the child/parent, higher global disease sever-
ity assessed by the physician, higher CHAQ score, lower
physical summary score of the CHQ, higher JADAS10
score, ongoing DMARDs, and not being in remission off
medication (Table 2). These associations remained
significant after adjusting for gender and age at the 8-
year visit in a multivariable logistic regression model
(results not shown).
All characteristics associated with school absence
mentioned above, were also associated with less partici-
pation in PE (Table 3), and these associations remained
significant when adjusting for gender and age at the 8-
year visit in a multivariable logistic regression model
(results not shown).
School absence more than 1 day the preceding 2
months before the baseline visit predicted higher school
absence at the eight-year visit (OR 1.2 (1.0–1.4), p = 0.044)
in the 92 children with both baseline and eight-year
information available. School absence at baseline did also
predict use of disease-modifying anti-rheumatic drugs, in-
cluding biologics (DMARDs) (OR 1.2 (1.1–1.5), p = 0.011,
n = 97), during the eight-year follow-up period. School ab-
sence more than 1 day at baseline was also a significant
predictor of not being in remission off medication (OR 1.4
(1.1–1.7), p = 0.007, n = 94) in a univariate model. School
absence at baseline remained significant for predicting
the use of DMARDs (OR 1.2 (1.0–1.5)) and for not
achieving remission (OR 1.3 (1.0–1.6)) when adjusting
for gender, age, and the number of active joints during
Table 1 Clinical characteristics at the eight-year study visit comparing children with juvenile idiopathic arthritis with and without
information on physical education (PE) and school attendance
Characteristics at final
study visit (n = 347)
Participants with information on PE
or school attendance (n = 285)
Participants without information on PE
or school attendance (n = 62)
N n (%) or median (IQR) N n (%) or median (IQR)
Female, n (%) 285 188 (66.0) 62 39 (62.9)
Age at disease onset, years 285 5.3 (2.3–9.4) 62 8.3 (3.8–11.2)
Cumulative joint count 285 6 (2–12) 62 4 (2–10)
Active joints 285 0.0 (0.0–0.0) 62 0.0 (0.0–0.0)
Physician GA, VAS 192 0.0 (0.0–0.9) 4 0.3 (0.1–1.8)
Patient/parent GA, VAS 216 0.0 (0.0–1.2) 3 0.3 (0.0–0.5)
Pain VAS 220 0.0 (0.0–1.3) 3 0.0 (0.0–0.5)
CHAQ score 285 0.0 (0.0–0.1) 8 0.0 (0.0–0.1)
CHQ-PF50, PhS score 160 52.5 (45.5–56.9) 4 46.8 (36.2–53.9)
CHQ-PF50, PsS score 160 54.8 (48.0–59.6) 4 40.9 (32.4–46.8)
DMARDs, n (%) 285 102 (35.8) 62 8 (12.9)
Oligoarticular persistent, n (%) 285 84 (29.5) 62 25 (40.3)
Oligoarticular extended, n (%) 285 49 (17.2) 62 8 (12.9)
Polyarticular RF negative, n (%) 285 58 (20.3) 62 7 (11.3)
Polyarticular RF positive, n (%) 285 2 (0.7) 62 1 (1.6)
Systemic arthritis, n (%) 285 8 (2.8) 62 1 (1.6)
Psoriatic arthritis, n (%) 285 13 (4.6) 62 0 (0)
Enthesitis-related arthritis, n (%) 285 29 (10.2) 62 12 (19.3)
Undifferentiated arthritis, n (%) 285 42 (14.7) 62 8 (12.9)
ESR mm/hour 193 7.0 (4.0–11.0) 14 8.5 (6.0–14.0)
CRP mg/liter 201 0.0 (0.0–5.0) 12 2.5 (0.0–7.5)
RF positive, n (%) 150 5 (3.3) 29 2 (6.9)
HLA-B27 positive, n (%) 274 62 (22.6) 52 11 (21.2)
ANA positive, n (%) 284 66 (23.2) 60 13 (21.7)
Values are the median (interquartile range, IQR), unless indicated otherwise. PE Physical education and school attendance assessed at the eight-year study visit, GA
Global assessment, VAS Visual analogue scale, CHAQ Childhood health assessment questionnaire, CHQ-PF50 Child health questionnaire parent form, PhS Physical
summary score, PsS Psychological summary score, DMARDs Disease-modifying antirheumatic drugs including biologics used at the final study visit, ESR Erythrocyte
sedimentation rate, CRP C-reactive protein, ANA Antinuclear antibody, assessed twice with at least 3 months interval, RF Rheumatoid factor, assessed twice with at
least 3 months interval, HLA-B27 Human leucocyte antigen
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Fig. 1 Number of days of school absence because of JIA during the last 2 months among participants in the Nordic JIA study. a assessed at the
baseline study visit 7 months after disease onset (n = 95). b assessed at the eight-year study visit (n = 274)
Table 2 Characteristics of 274 children in the Nordic JIA cohort according to school absence at the eight-year study visita
Characteristics at the eight-year visit n Absence ≤1 day (n = 228) Absence > 1 day (n = 46) OR (95% CI) P-value
Female, n (%) 274 148 (64.9) 32 (69.6) 1.2 (0.6–2.4) 0.545
Age disease onset, years 274 5.2 (2.3–9.2) 4.6 (2.3–8.7) 1.0 (0.9–1.1) 0.440
BMI 234 19.5 (17.3–21.6) 19.8 (17.2–24.8) 1.1 (1.0–1.2) 0.117
Cumulative joint count 274 5 (2–10) 11 (5–14) 1.0 (1.0–1.0) 0.007
Active joints 274 0 (0–0) 0 (0–1) 1.5 (1.2–1.9) 0.002
Physician GA 190 0.0 (0.0–0.5) 1.0 (0.2–2.1) 7.1 (2.7–18.5) < 0.001
Patient/parent GA 213 0.0 (0.0–0.6) 1.2 (0.0–2.5) 3.5 (1.8–6.8) < 0.001
Pain VAS 217 0.0 (0.0–0.8) 1.4 (1.0–3.5) 3.5 (1.9–6.5) < 0.001
CHAQ 274 0.0 (0.0–0.0) 0.3 (0.0–0.6) 10.1 (4.4–23.1) < 0.001
CHQ-PF50, PhS 159 53.4 (47.9–57.3) 41.8 (32.1–50.4) 0.9 (0.8–0.9) < 0.001
CHQ-PF50, PsS 159 54.9 (47.5–60.1) 54.3 (49.7–58.4) 1.0 (0.9–1.1) 0.792
DMARDs, n (%) 274 72 (31.6) 27 (58.7) 1.8 (1.3–2.7) 0.002
JADAS10 174 0.4 (0.0–2.2) 3.5 (0.6–6.1) 1.3 (1.2–1.5) < 0.001
Not in remission, n (%) 267 126 (56.8) 42 (93.3) 10.7 (3.2–35.5) < 0.001
ESR mm/hour 193 7.0 (4.0–11.0) 8.0 (4.0–13.0) 1.0 (1.0–1.1) 0.110
CRP mg/liter 201 0.0 (0.0–5.0) 0.0 (0.0–5.0) 1.0 (1.0–1.1) 0.168
RF positive 147 3 (2.6) 2 (6.3) 2.5 (0.4–15.6) 0.330
HLA-B27 positive 264 45 (20.6) 15 (32.6) 1.9 (0.9–3.7) 0.081
ANA positive 273 57 (25.1) 7 (15.2) 0.5 (0.2–1.3) 0.154
aPatient-/ proxy-reported school absence because of JIA during the preceding 2 months of the eight-year study visit with univariate logistic regression. Values are
the median (interquartile range, IQR), unless indicated otherwise, OR Odds ratio, CI Confidence interval, GA Global assessment, VAS Visual analogue scale, CHAQ
Childhood health assessment questionnaire, CHQ-PF50 Child health questionnaire parent form, PhS Physical summary score, PsS Psychological summary score,
DMARDs Disease-modifying antirheumatic drugs including biologics used at the final study visit, Not in remission Not in remission off medication according to the
Wallace preliminary criteria [21], ESR Erythrocyte sedimentation rate, CRP C-reactive protein, RF Rheumatoid factor, assessed twice with at least 3 months interval,
HLA-B27 Human leucocyte antigen, ANA Antinuclear antibody, assessed twice with at least 3 months interval
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Fig. 2 Participation in physical education in school within the last 2 months before the baseline study visit reported 7 months after disease onset
(n=89), at the 1-year visit (n=84), the 3-year visit (n=113), and the 8-year visit (n=242)
Table 3 Characteristics of 242 children in the Nordic JIA cohort according to PE participation at the 8 year visita




Partly or no PE
(n = 48)
OR (95% CI) P-value
Females, n (%) 242 119 (61.3) 39 (81.3) 2.7 (1.3–6.0) 0.012
Age at disease onset, years 242 4.4 (2.2–7.3) 4.6 (2.3–8.7) 1.0 (0.9–1.1) 0.398
BMI 205 18.9 (16.8–21.0) 21.2 (17.8–23.5) 1.1 (1.0–1.2) 0.013
Cumulative joint count 242 5 (2–9) 12 (4–16) 1.1 (1.0–1.1) < 0.001
Active joints 242 0 (0–0) 0 (0–2) 2.0 (1.4–2.8) < 0.001
Physician GA, VAS 188 0.0 (0.0–0.5) 0.9 (0.2–2.0) 7.1 (2.7–18.8) < 0.001
Patient/parent GA, VAS 212 0.0 (0.0–0.4) 1.6 (0.3–3.4) 6.1 (2.9–12.6) < 0.001
Pain VAS 216 0.0 (0.0–0.5) 2.0 (0.8–5.6) 7.8 (3.8–15.9) < 0.001
CHAQ score 242 0.0 (0.0–0.0) 0.3 (0.0–1.0) 15.0 (5.9–38.6) < 0.001
CHQ-PF50, PhS score 156 53.9 (48.5–57.3) 41.5 (31.1–48.2) 0.9 (0.8–0.9) < 0.001
CHQ-PF50, PsS score 156 56.0 (49.9–60.1) 50.3 (44.6–55.8) 0.9 (0.9–1.0) 0.010
DMARDs, n (%) 242 64 (33.0) 24 (50.0) 1.5 (1.1–2.2) 0.025
JADAS10 147 0.1 (0.0–1.9) 4.7 (1.9–8.0) 1.5 (1.3–1.7) < 0.001
Not in remission, n (%) 236 106 (55.8) 42 (91.3) 6.5 (2.5–17.2) < 0.001
ESR mm/hour 164 7.0 (4.0–10.0) 12.0 (5.0–16.0) 1.1 (1.0–1.1) 0.029
CRP mg/liter 169 0.0 (0.0–5.0) 0.0 (0.0–5.0) 1.0 (0.9–1.0) 0.851
RF positive, n (%) 123 1.0 (1.1) 0 n.a n.a
HLA-B27 positive, n (%) 233 42 (22.6) 10 (21.3) 0.9 (0.4–2.0) 0.848
ANA positive, n (%) 241 51 (26.4) 8 (16.7) 0.6 (0.2–1.3) 0.164
aPatient-/ proxy-reported participation in physical education due to JIA during the preceding 2 months of the eight-year study visit, univariate logistic regression.
Values are the median (interquartile range, IQR), unless indicated otherwise, OR Odds ratio, CI Confidence interval, GA Global assessment, VAS Visual analogue
scale, CHAQ Childhood health assessment questionnaire, CHQ-PF50 Child health questionnaire parent form, PhS Physical summary score, PsS Psychological
summary score, DMARDs Disease-modifying antirheumatic drugs including biologics used at the final study visit, Not in remission Not in remission off medication
according to the Wallace preliminary criteria [21], ESR Erythrocyte sedimentation rate, CRP C-reactive protein, RF Rheumatoid factor, assessed twice with at least 3
months interval, n.a. Not applicable, HLA-B27 Human leucocyte antigen, ANA Antinuclear antibody, assessed twice with at least 3 months interval
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the first 6 months in a multivariable regression model
(results not shown).
Discussion
We assessed school attendance and participation in
physical education in a prospective multi-center Nordic
JIA cohort. School attendance increased during the
disease course, and was generally high in children 8
years after disease onset in the Nordic JIA cohort.
Participation in PE in school was also high, but we found
less participation in PE in the ERA and undifferentiated
categories. Higher pain scores and disease activity mea-
sures were significantly associated with higher school
absence and less participation in PE at the eight-year
visit. Moreover, school absence at baseline predicted use
of DMARDs during the disease course, and not being in
remission 8 years after disease onset.
We did not find any other reports showing that base-
line school absence predicts adverse outcomes, such as
the need for DMARDs including biologic agents during
the disease course and not being in long-term remission
off medication. This finding was robust for adjustments
for gender, age, and number of active joints in early
disease, pointing to early school absence as a warning
sign of a more severe disease over time.
Our results indicate increased school absence in chil-
dren with JIA compared to healthy school children, since
the participants were asked to report JIA-related school
absence. We did not ask for school absence not related
to JIA. In Denmark, national statistics show a mean of
5.0% school absence in all school children [22]. Sixteen-
year old Norwegian students have a mean absence of 3
days and 9 h per school year [23]. This corresponds to 2
days (Denmark) or half a day (Norway) per two-month
period, in comparison to the reported additional 2.7 days
at baseline and 1.1 days at the eight-year visit of absence
related to JIA in our study.
A lower attendance rate was found in children with
JIA in a British cross-sectional study. Sturge et al. re-
ported a mean school attendance rate for children with
JIA of 92%, equivalent to 15 yearly absent days [24].
Attendance was lowest in the more severely affected
polyarticular JIA category in this study published in
1997 before the era of biologic treatment [24]. In a
Moroccan study Bouaddi et al. reported that as many as
33% of children with JIA were unable to attend school
due to their disease. In line with our results the risk of
increasing school absence was clearly associated to
higher disease activity [25], which is not uniformly re-
ported in all recent studies [26]. JIA may have a higher
impact on participation in less privileged countries, due
to limited access to expensive medical treatment [27].
Cultural and social traditions in coping with chronic
childhood diseases may also contribute to differences in
different regions of the world. Few data are available to
compare school participation in JIA to other chronic
childhood diseases. In the Swedish diabetes registry
Persson et al. report that type 1 diabetes had a small, but
significant, negative effect on schooling in terms of
school grades, and opportunities for further education
and careers [28]. Nilsson et al. found indications that
asthma may impair school performance in adolescence
in a population-based birth cohort [29]. In comparison,
Mease et al. reported that adults with ankylosing spon-
dylitis missed an average 6.3% of work time due to a
disease-related problems [30]. School absence is associ-
ated with increased school dropout, and the critical
years for decisions on education may coincide with the
period of transfer between pediatric and adult rheuma-
tology clinics with increased risk of disease flares and
lower health-related quality of life [31, 32]. In a system-
atic literature review young adults with arthritis had a
higher rate of unemployment compared to healthy peers
[21], underlining that school absence, social participation,
Table 4 Participation in physical education (PE) in 242 children at the eight-year study visit in the Nordic juvenile idiopathic arthritis
(JIA) cohort according to different JIA categories
JIA categories Full PE
(n = 194)
No or partly PE
(n = 48)
OR (95% CI)a P-value
n (%) n (%)
Oligoarticular persistent 73 (93.6) 5 (6.4) n.a n.a
Oligoarticular extended 33 (78.6) 9 (21.4) 4.0 (1.2–12.8) 0.020
Polyarticular RF negative 39 (78.0) 11 (22.0) 4.1 (1.3–12.7) 0.014
Polyarticular RF positive 0 0 n.a n.a
Systemic arthritis 5 (83.3) 1 (16.7) 2.9 (0.3–30.0) 0.367
Psoriatic arthritis 10 (83.3) 2 (16.7) 2.9 (0.5–17.1) 0.235
Enthesitis-related arthritis 13 (65.0) 7 (35.0) 7.9 (2.2–28.6) 0.002
Undifferentiated arthritis 21 (61.8) 13 (38.2) 9.0 (2.9–28.3) < 0.001
aUnivariate regression analysis with oligoarticular persistent arthritis as a reference category. OR Odds ratio, CI Confidence interval, RF Rheumatoid factor, n.a
Not applicable
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educational and vocational needs are central issues to ad-
dress in transitional care [32, 33]. Further follow-up of our
cohort regarding transition, educational level and employ-
ment rates are planned, but not yet available.
A majority of the children in our cohort participated
fully in physical education, and only 2.9% reported no
participation. In two recent reports from the Nordic
countries both Risum et al. and Nørgaard et al. found
similarly high participation rates in physical education
for children and adolescents with JIA in, respectively, a
Norwegian and a Danish controlled cross-sectional study
[10, 11]. In a German registry study Milatz et al. found
that 66% of 5879 school-aged children with JIA partici-
pated fully in school sports, while 16% did not partici-
pate [34]. We found less participation in PE in ERA and
the undifferentiated JIA category, in the latter many had
ERA-associated characteristics [10, 25]. An explanation
can be that ERA and undifferentiated arthritis are shown
to have higher pain scores, and higher disability than
other JIA categories. Also, adolescents with ERA had a
lower rate of remission, both in our cohort and in other
outcome studies [12, 35–37]. Physical activity is
especially recommended for adult spondyloarthropathies
[38, 39]. Regular physical activities have an impact on
muscular strength, physical and cardiovascular capacity, as
well as psychosocial health [40, 41]. There is evidence that
structured aerobic and neuromuscular training may
improve exercise capacity, functional performance, and
quality of life in children and adolescents with JIA [42, 43],
and in adults with rheumatic inflammatory diseases [44]. A
positive association between increased bone mass and
physical activity during the life course, and particularly in
the growth period, is found in a literature review [45].
Recent research also points to an anti-inflammatory effect
of exercise that may be mediated by muscle-derived cyto-
kines [9, 46]. Armbrust el al examined effect of an internet
program to promote physical activity in children with JIA,
and report that full participation in physical education
increased from 57 to 71% in their intervention group of 28
children [42]. This knowledge underlines the need to pro-
vide satisfactory tailored physical education programs to
children with JIA that do not take part in PE.
The prospective, observational cohort design and
population-based context are the strengths of this multi-
center cohort study. The proportion of children lost to
follow-up is small compared to other longitudinal stud-
ies [47–49]. A novelty is that our study can show school
attendance and participation development longitudinally
during the disease course, assess associations of partici-
pation to patient and disease characteristics, and also
assess baseline school absence as a predictor of adverse
outcome. Since this information was collected at a
hospital visit, we report “more than one of day absence”
as absence because of JIA. Very few patients will have
more than this 1 day spent for hospital visits during the
last 2 months, which is the period we asked for. A weak-
ness is that there were no control group, and not all of
the children in our cohort had information on school
and physical education at all four time-points during the
follow-up period. Recall bias may have influenced the
data, since participation during the previous 2 months
was registered by the child or the parents at a study visit.
Asking for school absence related to JIA also leaves the
judgment to the individual participants as to whether
intercurrent infectious diseases or psychosocial problems
were considered related to JIA or not.
Conclusion
Participation in school and PE is high in this eight-year
follow-up of the Nordic JIA cohort, but lower participa-
tion in PE was found among children with ERA and the
undifferentiated categories. Increased school absence at
baseline predicted long-term adverse outcome in terms
of use of DMARDs including biologic agents and not
achieving remission off medications.
Increased school absence and less participation in
physical education 8 years after disease onset was also
significantly associated with higher disease activity, func-
tional disability and lower quality of life-measures.
Attention is warranted to ongoing promotion of physical
activity in children with JIA. School attendance needs
continuous focus in JIA follow-up, especially in the
vulnerable transition period for adolescents.
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